Skip to main content
Erschienen in: Clinical Rheumatology 12/2016

12.10.2016 | Original Article

The effect of total hip replacement on employment in patients with ankylosing spondylitis

verfasst von: Chongru He, Xiaokang He, Wenwen Tong, Wei Zheng, Tianfang Zhang, Jinzhu Zhao, Weidong Xu

Erschienen in: Clinical Rheumatology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Although total hip replacement (THR) has been proven to be effective, the effect of THR on employment in ankylosing spondylitis (AS) in Chinese population is still unknown. We aimed to demonstrate whether or not patients with AS returned to work following THR and factors associated with the work ability after THR. We performed a retrospective study including a total number of 128 AS patients undergoing THR between 2009 and 2013. Presurgery and postsurgery data including disease state, work status, type of job, and time of resuming work were collected. Factors associated with early return to work were assessed through ordinal regression. Eighty-seven of 128 patients (68 %) were employed within 1 year before THR and 98 returned to work after surgery. Among them, 21, 46, and 31 resumed work by 3, 6, and 12 months postoperation, respectively. Multivariate ordinal regression showed that patients with unilateral THR, younger age, lower BASFI score, employed presurgery, and low or moderate physical demand were more likely to resume work earlier. Most individuals working presurgery returned to work after THR. For young AS patients with hip involvement, THR is an effective treatment for improving and maintaining work ability.
Literatur
2.
Zurück zum Zitat Zeng QY, Chen R, Xiao ZY et al (2004) Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. J Rheumatol 31:2439–2443PubMed Zeng QY, Chen R, Xiao ZY et al (2004) Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. J Rheumatol 31:2439–2443PubMed
3.
Zurück zum Zitat Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 30:2245–2251PubMed Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 30:2245–2251PubMed
4.
Zurück zum Zitat Wigley RD, Zhang NZ, Zeng QY et al (1994) Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol 21:1484–1490PubMed Wigley RD, Zhang NZ, Zeng QY et al (1994) Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol 21:1484–1490PubMed
7.
Zurück zum Zitat Vander Cruyssen B, Muñoz-Gomariz E, Font P et al (2010) Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) 49:73–81. doi:10.1093/rheumatology/kep174 CrossRef Vander Cruyssen B, Muñoz-Gomariz E, Font P et al (2010) Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) 49:73–81. doi:10.​1093/​rheumatology/​kep174 CrossRef
10.
Zurück zum Zitat Mau W, Listing J, Huscher D, Zeidler H, Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32:721–728PubMed Mau W, Listing J, Huscher D, Zeidler H, Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32:721–728PubMed
11.
Zurück zum Zitat Boonen A (2002) Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 20:S23–S26PubMed Boonen A (2002) Socioeconomic consequences of ankylosing spondylitis. Clin Exp Rheumatol 20:S23–S26PubMed
13.
Zurück zum Zitat Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780–785. doi:10.2106/JBJS.F.00222 PubMed Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780–785. doi:10.​2106/​JBJS.​F.​00222 PubMed
18.
Zurück zum Zitat Kubiak EN, Moskovich R, Errico TJ, Di Cesare PE (2005) Orthopaedic management of ankylosing spondylitis. J Am Acad Orthop Surg 13:267–278CrossRefPubMed Kubiak EN, Moskovich R, Errico TJ, Di Cesare PE (2005) Orthopaedic management of ankylosing spondylitis. J Am Acad Orthop Surg 13:267–278CrossRefPubMed
19.
Zurück zum Zitat van der Heijde D, Han C, DeVlam K et al (2006) Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum 55:569–574. doi:10.1002/art.22097 CrossRefPubMed van der Heijde D, Han C, DeVlam K et al (2006) Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum 55:569–574. doi:10.​1002/​art.​22097 CrossRefPubMed
20.
Zurück zum Zitat Keat AC, Gaffney K, Gilbert AK, Harris C, Leeder J (2008) Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis. Rheumatology (Oxford) 47:481–483. doi:10.1093/rheumatology/ken010 CrossRef Keat AC, Gaffney K, Gilbert AK, Harris C, Leeder J (2008) Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis. Rheumatology (Oxford) 47:481–483. doi:10.​1093/​rheumatology/​ken010 CrossRef
21.
Zurück zum Zitat Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
22.
Zurück zum Zitat Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1:904–907CrossRefPubMed Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1:904–907CrossRefPubMed
23.
Zurück zum Zitat Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704–706CrossRefPubMed Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704–706CrossRefPubMed
24.
Zurück zum Zitat Yang M, Xu M, Pan X et al (2013) Epidemiological comparison of clinical manifestations according to HLA-B*27 carrier status of Chinese ankylosing spondylitis patients. Tissue Antigens 82:338–343. doi:10.1111/tan.12186 CrossRefPubMed Yang M, Xu M, Pan X et al (2013) Epidemiological comparison of clinical manifestations according to HLA-B*27 carrier status of Chinese ankylosing spondylitis patients. Tissue Antigens 82:338–343. doi:10.​1111/​tan.​12186 CrossRefPubMed
25.
Zurück zum Zitat Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
26.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
27.
Zurück zum Zitat Lin Z, Gu J, He P et al (2011) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int 31:233–238. doi:10.1007/s00296-009-1313-9 CrossRefPubMed Lin Z, Gu J, He P et al (2011) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int 31:233–238. doi:10.​1007/​s00296-009-1313-9 CrossRefPubMed
28.
Zurück zum Zitat Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358. doi:10.1136/ard.60.4.353 CrossRefPubMedPubMedCentral Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358. doi:10.​1136/​ard.​60.​4.​353 CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Dorr LD, Kane TJ 3rd, Conaty JP (1994) Long-term results of cemented total hip arthroplasty in patients 45 years old or younger: a 16-year follow-up study. J Arthroplast 9:453–456CrossRef Dorr LD, Kane TJ 3rd, Conaty JP (1994) Long-term results of cemented total hip arthroplasty in patients 45 years old or younger: a 16-year follow-up study. J Arthroplast 9:453–456CrossRef
31.
Zurück zum Zitat Tennent TD, Goddard NJ (2000) Current attitudes to total hip replacement in the younger patient: results of a national survey. Ann R Coll Surg Engl 82:33–38PubMedPubMedCentral Tennent TD, Goddard NJ (2000) Current attitudes to total hip replacement in the younger patient: results of a national survey. Ann R Coll Surg Engl 82:33–38PubMedPubMedCentral
32.
Zurück zum Zitat Cakar E, Taskaynatan MA, Dincer U, Kiralp MZ, Durmus O, Ozgül A (2009) Work disability in ankylosing spondylitis: differences among working and work-disabled patients. Clin Rheumatol 28:1309–1314. doi:10.1007/s10067-009-1249-1 CrossRefPubMed Cakar E, Taskaynatan MA, Dincer U, Kiralp MZ, Durmus O, Ozgül A (2009) Work disability in ankylosing spondylitis: differences among working and work-disabled patients. Clin Rheumatol 28:1309–1314. doi:10.​1007/​s10067-009-1249-1 CrossRefPubMed
37.
39.
Zurück zum Zitat Gignac MA, Badley EM, Lacaille D, Cott CC, Adam P, Anis AH (2004) Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum 51:909–916. doi:10.1002/art.20822 CrossRefPubMed Gignac MA, Badley EM, Lacaille D, Cott CC, Adam P, Anis AH (2004) Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum 51:909–916. doi:10.​1002/​art.​20822 CrossRefPubMed
Metadaten
Titel
The effect of total hip replacement on employment in patients with ankylosing spondylitis
verfasst von
Chongru He
Xiaokang He
Wenwen Tong
Wei Zheng
Tianfang Zhang
Jinzhu Zhao
Weidong Xu
Publikationsdatum
12.10.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3431-6

Weitere Artikel der Ausgabe 12/2016

Clinical Rheumatology 12/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.